首页> 外文期刊>RSC Advances >Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44(+) cancer cells
【24h】

Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44(+) cancer cells

机译:透明质酸基银纳米粒子的绿色合成及其增强递送至CD44(+)癌细胞

获取原文
获取原文并翻译 | 示例
           

摘要

The potent antitumor activities of silver nanoparticles (AgNP) have attracted great attention. However, the application of AgNP is restricted by its non-specific delivery and poor cellular uptake. We developed a novel hyaluronic acid (HA)-based strategy for the green synthesis of AgNP, in which HA was used as the reducing agent and stabilizer. More importantly, HA is a ligand of CD44, and the HA-modified AgNP can target CD44 receptors that are overexpressed in many types of cancer cells. The CD44-dependent endocytosis can significantly increase the intracellular delivery of HA-AgNP, compared to the non-modified one. The antitumor efficacy was significantly improved by HA modification. Furthermore, we found that multiple mechanisms were involved for the enhanced anticancer activities of HA-AgNP, including the decline of mitochondrial membrane potential, cell-cycle arrest, apoptosis, and autophagy. The HA-based strategy for green synthesis and CD44-targeting delivery provided a promising solution for AgNP-mediated cancer treatment.
机译:银纳米粒子(AGNP)的有效抗肿瘤活性引起了极大的关注。然而,AGNP的应用受其非特异性递送和较差的细胞吸收的限制。我们开发了一种新的透明质酸(HA)基于AgNP的绿色合成的策略,其中HA被用作还原剂和稳定剂。更重要的是,HA是CD44的配体,HA-修饰的AgNP可以靶向许多类型的癌细胞中过表达的CD44受体。与未改性的,CD44依赖性内吞作用可以显着增加HA-AGNP的细胞内递送。通过HA改性显着提高了抗肿瘤功效。此外,我们发现多种机制参与了HA-AGNP的增强的抗癌活性,包括线粒体膜潜力,细胞周期骤停,细胞凋亡和自噬的下降。基于HA的绿色合成和CD44靶向递送的策略为AGNP介导的癌症治疗提供了有希望的解决方案。

著录项

  • 来源
    《RSC Advances》 |2015年第54期|共8页
  • 作者单位

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Guangzhou Univ Chinese Med Sch Chinese Mat Med Guangzhou 501450 Guangdong Peoples R China;

    Hubei Biol Med Ind Technol Inst Co Ltd Wuhan 430075 Peoples R China;

    Guangzhou Univ Chinese Med Inst Trop Med Guangzhou 501450 Guangdong Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号